ERN RARE-LIVER Webinar Series 25.06.2024: Liver cyst infection, the feared complication of cystic liver disease

Liver cyst infection is a rare but one of the most challenging complications of cystic liver disease. Liver cyst infection often necessitate extended hospital admissions, require long-term antibiotic treatment and frequently recur, which all significantly impact the quality of life of these patients. Both diagnosis and treatment are a considerable challenge in daily clinical practice. The European Association for the Study of the Liver (EASL) recently published a clinical practice guideline on the management of cystic liver disease. In addition an expert consensus on how to manage these complex patients with a cyst infection has been formulated. The goal of the webinar is to inform the wider community of the clinical decision framework which was developed, to provide the clinician tools to timely diagnose and adequately treat patients presenting with a liver cyst infection.

1. Cyst infection – a case presentation by Anouar Aznou, Amsterdam UMC 

2. Diagnosis of Cyst Infection by Marten Lantinga, Amsterdam UMC 

3. Management of Cyst Infection by Pavel Strnad, University Hospital RWTH Aachen 

Chairs: Marten Lantinga (Amsterdam UMC); Richard Taubert (Hannover Medical School) 

Short bios:* 
*Marten Lantinga is gastroenterologist and hepatologist at the Dept. Gastroenterology and Hepatology of the Amsterdam University Medical Center in Amsterdam, the Netherlands. His research interests include pharmacokinetics of drugs in liver cirrhosis, drug-related liver damage and applications of (experimental) drugs in (rare) liver diseases. His clinical focus in on end-stage liver disease and portal hypertension. 
 

Richard Taubert is gastroenterologist and hepatologist at the Dept. Gastroenterology, Hepatology and Endocrinology of the Hannover Medical School in Hannover/Germany. His clinical focus is the care of patients with rare and end-stage liver diseases before and after liver transplantation. His research focuses on immune mediated liver diseases before and after transplantation. He serves as the Hannover Medical School representative of the European Reference Network on rare liver diseases. 

Speakers:

Anouar Aznou (Amsterdam UMC); Pavel Strnad (University Hospital RWTH Aachen) 

Short bios:

Anouar Aznou obtained a medical degree at the VU Univeristy in Amsterdam. During his studies, he was a member of the study programme committee of the faculty of medicine and worked several years as research assistant in the departments of boths Internal Medicine as well as Gastroenterology and Hepatology. He is currently working as ward physician on the gastroenterology and hepatolgy ward of the Amsterdam University Medical Center (AUMC). 

Pavel Strnad is a full professor and leading physician at the University Hospital Aachen, Germany. Since 2008, he is heading his own research lab focusing on translational gastroenterology. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading the European initiative for study of alpha1-antitrypsin deficiency-associated liver disease. His interest include (but are not limited to) metabolic liver disease, liver cirrhosis and complications, keratins and iron metabolism. His clinical focus is on emerging drugs, end-stage liver disease and liver transplantation.

Please register under this link: https://uke-de.zoom-x.de/meeting/register/u50of-ygpjojHtRi4AjSYyBSRvvb3LlaDoHM